Abstract
Poorly differentiated synovial sarcoma is a rare soft tissue tumor. We studied a case arising in the pleural cavity of a young subject, characterised by the presence of spindle cell, small cell, and large epithelioid cell areas. We performed stains for mucosubstances and analysed the expression of cytokeratins 5/6, 7, 8, 18, 19, CEA, CD34, Ber-Ep4 and calretinin to characterize the phenotype of this neoplasm. We furthermore assessed immunohistochemically the presence of p53, Bcl-2, Bax and caspase 3, four apoptotic markers, to evaluate a relationship between apoptotic activity and the behaviour of this tumor. Our findings showed a strong presence of calretinin, p53 and Bcl-2 in all three areas. The possibility that poorly differentiated synovial sarcoma could be calretininpositive was a new data, to our knowledge, and it could be of some importance in diagnostic pathology. Moreover, the negligible positivity for Bax and caspase 3 suggested that the minor role of programmed cell death could be one of the causes of the aggressive behaviour of this tumor. These data also suggest that the reduction of apoptotic phenomena in poorly differentiated synovial sarcoma could be considered one of the major mechanisms of tumoral growth.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Abenoza P, Manivel JC, Swanson PE, et al: Synovial sarcoma: ultrastructural study and immunohistochemical analysis by a combined peroxidase-antiperoxidase/avidin-biotin complex procedure. Hum Pathol 17:1107–1115, 1986.
Bissonnette RP, Echeverri F: Apoptotic cells induced by c-myc are inhibited by Bcl-2. Nature 359:552–554, 1992.
Bubendorf L, Sauter G, Moch H, et al: Prognostic significance of Bcl-2 in clinically localized prostate cancer. Am J Surg Pathol 148:1557–1565, 1996.
Chilosi M, Facchetti F, Dei Tos AP, et al: Bcl-2 expression in pleural and extrapleural solitary fibrous tumors. J Pathol 181:362–367, 1997.
Dei Tos AP, Wadden C, Calonje E: Immunohistochemical demonstration of glycoprotein p30/30 MIC2 (CD99) in synovial sarcoma. A potential cause of diagnostic confusion. Applied immunohistochemistry 3:168–173, 1995.
Doglioni C, Dei Tos AP, Taurino T, et al: Calretinin: a novel immunocytochemical marker for mesothelioma. Am J Surg Pathol 20:1037–1046, 1996.
Enzinger FM, Weiss SW: Soft tissue tumors. St. Louis, Mosby, 1995.
Fisher C: Ultrastructural and immunohistochemical features of epithelial differentiation in monophasic and biphasic tumors. Hum Pathol 17:996–1008, 1986.
Folpe AL, Schmidt RA, Chapman D, et al: Poorly differentiated synovial sarcoma. Immunohistochemical distinction from primitive neuroectodermal tumors and high grade malignant peripheral nerve sheath tumors. Am J Surg Pathol 22:673–682, 1998.
Gaertner E, Zeren EH, Fleming MV, et al: Biphasic synovial sarcoma arising in the pleural cavity. A clinicopathologic study of five cases. Am J Surg Pathol 138:505–513, 1991.
Hall PA, Levison DA: Biphasic tumor: clues to possible histogenesis in developmental processes. J Pathol 159:1–2, 1989.
Joensuu H, Pylkkanen L, Toikkanen S: Bcl-2 protein expression and long term survival in breast cancer. Am J Pathol 145:1191–1198, 1994.
Kulig E, Jin L, Qian X, et al: Apoptosis in non-tumorous and neoplastic human pituitaries. Expression of the Bcl-2 family of proteis. Am J Pathol 154:767–774, 1999.
Lu QT, Abel P, Foster CS, et al: Bcl-2: role in epithelial differentiation and oncogenesis. Hum Pathol 27:102–110, 1996.
McPake CR, Tillman DM, Poquette CA, et al: Bax is an important determinant of chemosensitivity in pediatric tumor cell lines independent of Bcl-2 expression and p53 status. Oncol Res 10:235–244, 1998.
Meis-Kindblom JM, Stenman G, Kindblom LG: Differential diagnosis of small round cell tumors. Semin Diagn Pathol 13:213–241, 1996.
Nakanishi H, Ohsawa M, Naka N, et al: Immunohistochemical detection of Bcl-2 and p53 proteins and apoptosis in soft tissue sarcoma: their correlation with prognosis. Oncology 54:238–244, 1997.
Nicholson AG, Goldstraw P, Fisher C: Synovial sarcoma of the pleura and its differentiation from other primary pleural tumors: a clinicopathological and immunohistochemical review of three cases. Histopathology 33:508–513, 1998.
Oltavi ZN, Milliman CL, Korsmeyer SJ: Bcl-2 hemerodimer in vivo with a conserved homologue, Bax, that accelerates programmed cell death. Cell 74:609–619, 1993.
Ordonez NG, Mahfouz SM, MacKay B: Synovial sarcoma: an immunohistochemical and ultrastructural study. Hum Pathol 21:733–749, 1990.
Ordonez NG: The immunohistochemical diagnosis of epithelial mesothelioma. Hum Pathol 30:313–323, 1999.
Salisbury JR, Isaacson PG: Synovial sarcoma: an immunohistochemical study. J Pathol 147:49–57, 1985.
Segers K, Ramael M, Singh Sk, et al: Immunoreactivity for Bcl-2 protein in malignant mesothelioma and non-neoplastic mesothelium. Virchows Arch 424:631–634, 1994.
Singer S, Baldini EH, Demetri GD, et al: Synovial sarcoma: prognostic significance of tumor size, margin sesection and mitotic activity for survival. J Clin Oncol 14:1201–1208, 1996.
Suster S, Fisher C, Moran CA: Expression of Bcl-2 oncoprotein in benign and malign spindle cell tumors of soft tissue, skin, serosal surfaces and gastrointestinal tract. Am J Surg Pathol 22:863–872, 1998.
Tormanen U, Eerole AK, Rainio P, et al: Enhanced apoptosis predicts shortened survival in non-small cell lung carcinoma. Cancer Res 55:595–602, 1995.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Cappello, F., Bellafiore, M., Bucchieri, F. et al. Poorly differentiated synovial sarcoma: A case report. Pathol. Oncol. Res. 7, 63–66 (2001). https://doi.org/10.1007/BF03032608
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF03032608